Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
Stock Score/grades
The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company
- Altman Z Score -2.64
- Piotroski Score 2.00
- Grade Perform
- Symbol (ACST)
- Company Acasti Pharma Inc.
- Price $3.37
- Changes Percentage (4.01%)
- Change $0.13
- Day Low $3.20
- Day High $3.45
- Year High $3.60
Acasti Pharma Inc., a biopharmaceutical company, engages in the development and commercialization of pharmaceutical products for cardiovascular diseases. It is evaluating strategic partnerships for the clinical development of CaPre. The company was incorporated in 2002 and is headquartered in Laval, Canada.
- Last Earnings
- Ex-Dividend for 5/16 Dividend
- Dividend Payable
- Today N/A
- Next Earnings (Estimated) 11/10/2024
- Fiscal Year End N/A
- Average Stock Price Target $0.00
- High Stock Price Target $0.00
- Low Stock Price Target $0.00
- Potential Upside/Downside N/A
- Consensus Rating Sell
- Rating Score (0-4) N/A
- Research Coverage N/A
- EPS (Most Recent Fiscal Year) -$5.68
- Trailing P/E Ratio -0.54
- Forward P/E Ratio -0.54
- P/E Growth -0.54
- Net Income $-12,853,000
Income Statement
Quarterly
Annual
Latest News of ACST
The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.
-
Is Acasti Pharma (NASDAQ:ACST) In A Good Position To Invest In Growth?
While unprofitable businesses like biotech and mining exploration companies may not see their stock prices immediately drop, they carry risks due to potential cash burn. Analyzing Acasti Pharma's cash...
By Yahoo! Finance | 4 months ago
